Get the Stockscreener App
17.77
1.31%
0.23
Ceribell Inc stock is traded at $17.77, with a volume of 196.20K.
It is up +1.31% in the last 24 hours and down -11.81% over the past month.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
See More
Previous Close:
$17.54
Open:
$17.63
24h Volume:
196.20K
Relative Volume:
0.47
Market Cap:
$668.88M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.23%
1M Performance:
-11.81%
6M Performance:
+44.12%
1Y Performance:
-25.21%
1-Day Range:
$17.41
$17.95
1-Week Range:
$16.84
$19.52
52-Week Range:
$10.01
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
17.77 | 660.23M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Ceribell Earnings Call Highlights Strong Growth, Rising Costs - TipRanks
CeriBell (NASDAQ:CBLL) CTO Sells $147,587.75 in Stock - MarketBeat
Ceribell’s Woo sells $202k in shares - Investing.com India
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord - Insider Monkey
CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector - DirectorsTalk Interviews
CBLL Should I Buy - Intellectia AI
Earnings Call Summary | Ceribell(CBLL.US) Q4 2025 Earnings Conference - 富途牛牛
CeriBell (CBLL) Revenue Growth To US$24.8m Tests Premium Valuation Narrative - simplywall.st
Top Ceribell Executives Quietly Unload Shares in Coordinated Insider Move - TipRanks
Insider Selling: CeriBell (NASDAQ:CBLL) VP Sells 569 Shares of Stock - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 705 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 781 Shares - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CFO Sells 808 Shares of Stock - MarketBeat
[Form 4] Ceribell, Inc. Insider Trading Activity - Stock Titan
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating - TipRanks
CeriBell (NASDAQ:CBLL) Shares Gap DownTime to Sell? - MarketBeat
Ceribell Inc. debuts AI-enabled neonatal EEG at NEO Pediatrix Conference - Traders Union
CeriBell revenue up 34% to USD 24.8M in Q4 2025 - Medical Buyer
CeriBell Q4 Revenue Rises 34%; Projects Revenue Growth Of 25%-29% For FY'26 - Nasdaq
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
CeriBell (CBLL) Q4 2025 Earnings Call Transcript - The Globe and Mail
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating - TipRanks
CeriBell Q4 Earnings Call Highlights - Yahoo Finance
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq
CeriBell, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook - ChartMill
Ceribell Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ceribell beats Q4 revenue expectations - TradingView
Ceribell, Inc. SEC 10-K Report - TradingView
CeriBell, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Ceribell (NASDAQ: CBLL) posts 36% 2025 revenue growth but wider net loss - Stock Titan
Earnings Flash (CBLL) Ceribell, Inc. Reports Q4 Revenue $24.8M, vs. FactSet Est of $23.9M - marketscreener.com
CeriBell, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com
CeriBell, Inc. (CBLL) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Institution Moves: Why is CeriBell Inc stock going upWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
CeriBell's Earnings: A Preview - Benzinga
Josef Parvizi Sells 16,714 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell (CBLL) director Parvizi sells $338,792 in shares - Investing.com South Africa
Ceribell (CBLL) director Parvizi sells $338,792 in shares By Investing.com - Investing.com Nigeria
Ceribell Insider Sold Shares Worth $338,793, According to a Recent SEC Filing - marketscreener.com
CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead O - GuruFocus
Ceribell, Inc. (CBLL) Receives a Buy from BTIG - The Globe and Mail
Ceribell Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
CeriBell, Inc. (CBLL) Stock Analysis: Is A 38.63% Upside Within Reach? - DirectorsTalk Interviews
Insider trusts tied to Ceribell (CBLL) sell 8,286 shares at $20 - Stock Titan
Ceribell to Participate in Upcoming March Investor Conferences - The Manila Times
CenterBook Partners LP Increases Stake in CeriBell, Inc. $CBLL - MarketBeat
CeriBell, Inc. (CBLL) Stock Analysis: A 41% Upside Potential In Revolutionary Medical Devices - DirectorsTalk Interviews
What drives CeriBell Inc.’s stock price2025 Big Picture & Capital Protection Trade Alerts - mfd.ru
Market Overview: How sensitive is CeriBell Inc to inflation2025 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):